supply of - d cfa re 67 acenocoumarol 1 mg tab , d cfa re 67 tranexamic acid 500 mg 5ml inj , d cfa re 67 phytomenadione vit k 1mg 0 dot 5ml inj , d cfa re 67 choline salicylate and benzalkonium chloride gel of 10 ml , d cfa re 67 prasugrel 10 mg tab , d cfa re 67 rivaroxaban 20 mg tab , d cfa re 67 mannitol 20 100 ml bottle , d cfa re 67 carvedilol 3 dot 125mg tab , d cfa re 67 carvedilol 12dot5 mg tab , d cfa re 67 ticagrelor 90mg tab , d cfa re 67 diltiazem 60 mg tab , d cfa re 67 diltiazem c

Indian Army has invited bids for the supply of - d cfa re 67 acenocoumarol 1 mg tab , d cfa re 67 tranexamic acid 500 mg 5ml inj , d cfa re 67 phytomenadione vit k 1mg 0 dot 5ml inj , d cfa re 67 choline salicylate and benzalkonium chloride gel of 10 ml , d cfa re 67 prasugrel 10 mg tab , d cfa re 67 rivaroxaban 20 mg tab , d cfa re 67 mannitol 20 100 ml bottle , d cfa re 67 carvedilol 3 dot 125mg tab , d cfa re 67 carvedilol 12dot5 mg tab , d cfa re 67 ticagrelor 90mg tab , d cfa re 67 diltiazem 60 mg tab , d cfa re 67 diltiazem controlled delivery 90mg tab , d cfa re 67 diltiazem 5mgml inj , d cfa re 67 bosentan 62 dot 5 mg tab , d cfa re 67 perindopril 8mg tab , d cfa re 67 adenosine 3 mgml 2 ml inj , d cfa re 67 adenosine 3 mgml 10 ml inj , d cfa re 67 dabigatran etexilate 150mg tab , d cfa re 67 aspirin 75mg rosuvastatin 10mg tab , d cfa re 67 amiodarone hcl 150 mg 3 ml inj , d cfa re 67 apixaban 2 dot 5mg tab , d cfa re 67 apixaban 5mg tab , d cfa re 67 esmolol 100 mg 10 ml inj , d cfa re 67 lignocaine hcl solution 2 for iv use 50 ml inj , d cfa re 67 enalapril maleate 10 mg tab , d cfa re 67 enalapril maleate 2 dot 5 mg tab , d cfa re 67 nebivolol 5mg tab , d cfa re 67 labetalol hcl 100 mg tab , d cfa re 67 nifedipine retard 20 mg captab , d cfa re 67 digoxin 0 dot 25 mg tab , d cfa re 67 digoxin 0 dot 5 mg 2 ml inj , d cfa re 67 verapamil sustained release 120mg tab , d cfa re 67 metoprolol xl 25mg tab , d cfa re 67 vasopressin 20 unitsml inj 1ml ampoule , d cfa re 67 dopamine hcl 40 mgml 5ml inj , d cfa re 67 dobutamine hcl 250 mg 5 ml inj , d cfa re 67 streptokinase 15 lac iu inj , d cfa re 67 telmisartan 40 mg amlodipine 10 mg tab , d cfa re 67 telmisartan 40 mg amlodipine 10 mg hydrochlorothiazide 12 dot 5 mg tab , d cfa re 67 warfarin 5 mg tab , d cfa re 67 clonidine 100 mcg tab , d cfa re 67 labetalol hcl 5mgml 4ml inj , d cfa re 67 losartan 50 mg tab , d cfa re 67 phenylepherine 10 mg 1 ml inj , d cfa re 67 prazosin 5 mg sustained releaseslow release tab , d cfa re 67 enalapril 5 mg tab , d cfa re 67 methyldopa tab 250mg , d cfa re 67 ramipiril 5 mg hydrochlorothiazide 12dot5 mg tab , d cfa re 67 bisoprolol 5 mg tab , d cfa re 67 metoprolol 12 dot 5 mg tab , d cfa re 67 nebivolol 5 mg tab , d cfa re 67 nicorandil 5 mg tab , d cfa re 67 antiseptic mouth wash containing sodium fluoride triclosan bott of 100 150ml , d cfa re 67 chlorhexidine mouth wash with 0 dot 12 sugar alcohol free bottle of 450 500 ml in amber coloured bottle , d cfa re 67 triamcinolone acetonide 0 dot 1 for oral use tube of 5 gm , d cfa re 67 halobetasol propionate 0 dot 05 ointment tube of 15gm , d cfa re 67 sertaconazole 2 cream tube of 30gm , d cfa re 67 calamine powder - drugs and pharmacetical produts | quantity - 51619. The estimated project cost is ₹0.01 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 21 September 2026, with the technical opening scheduled for 21 September 2026.